Epistem Collaborating with Sanofi-Aventis on Oncology

The UK biotech firm will provide Sanofi-Aventis US with its biomarker gene expression profiling and immunohistochemistry technologies.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories